Abstract |
This review discusses the 2013 American College of Cardiology (ACC)/American Heart Association (AHA) Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults and compares it with the 2014 National Lipid Association (NLA) Recommendations for Patient-Centered Management of Dyslipidemia. The review discusses some of the distinctions between the guidelines, including how to determine a patient's atherosclerotic cardiovascular disease risk, the role of lipoprotein treatment targets, the importance of moderate- and high-intensity statin therapy, and the use of nonstatin therapy in light of the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) trial.
|
Authors | Bhavin B Adhyaru, Terry A Jacobson |
Journal | Cardiology clinics
(Cardiol Clin)
Vol. 33
Issue 2
Pg. 181-96
(May 2015)
ISSN: 1558-2264 [Electronic] Netherlands |
PMID | 25939292
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
|
Topics |
- American Heart Association
- Atherosclerosis
(diagnosis, epidemiology, therapy)
- Cardiology
- Disease Management
- Humans
- Lipids
(blood)
- Morbidity
(trends)
- Patient-Centered Care
(methods)
- Practice Guidelines as Topic
- Risk Assessment
- Risk Factors
- United States
(epidemiology)
|